Biomarker concentrations by period and between-period change in participant-specific biomarker concentrations in COPD patients.</p
Chronic obstructive pulmonary disease (COPD) is one of the world’s most common chronic diseases, and...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
SummaryBackgroundRecent studies show that COPD patients exhibit low-grade systemic inflammation, and...
Changes in the concentration of biochemical indicators among the participants during the follow-up p...
COPD is lagging in the precision medicine race. The term COPD was designed to be an umbrella term, w...
<p>Characteristics of COPD patients and hospital care variables according to whether serum AAT level...
INTRODUCTION: Clinical decisions in chronic obstructive pulmonary disease (COPD) treatment often uti...
BACKGROUND: There is a need for biomarkers to better characterise individuals with COPD and to aid w...
ABSTRACT: Chronic obstructive pulmonary disease (COPD) is still a leading cause of morbidity and mor...
Correlation analyses between the 15 differentially regulated proteins and main clinical parameters i...
BACKGROUND Measurements of pulmonary biomarkers can be used to monitor airway inflammation in chroni...
Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous. In particular the a...
Abstract Background There is a need for biomarkers to better characterise individuals with COPD and ...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
Chronic obstructive pulmonary disease (COPD) is one of the world’s most common chronic diseases, and...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
SummaryBackgroundRecent studies show that COPD patients exhibit low-grade systemic inflammation, and...
Changes in the concentration of biochemical indicators among the participants during the follow-up p...
COPD is lagging in the precision medicine race. The term COPD was designed to be an umbrella term, w...
<p>Characteristics of COPD patients and hospital care variables according to whether serum AAT level...
INTRODUCTION: Clinical decisions in chronic obstructive pulmonary disease (COPD) treatment often uti...
BACKGROUND: There is a need for biomarkers to better characterise individuals with COPD and to aid w...
ABSTRACT: Chronic obstructive pulmonary disease (COPD) is still a leading cause of morbidity and mor...
Correlation analyses between the 15 differentially regulated proteins and main clinical parameters i...
BACKGROUND Measurements of pulmonary biomarkers can be used to monitor airway inflammation in chroni...
Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous. In particular the a...
Abstract Background There is a need for biomarkers to better characterise individuals with COPD and ...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
Chronic obstructive pulmonary disease (COPD) is one of the world’s most common chronic diseases, and...
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways...
SummaryBackgroundRecent studies show that COPD patients exhibit low-grade systemic inflammation, and...